American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

RSS icon
U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 

November 11, 2022
Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

November 11, 2022
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

November 10, 2022
Medtronic’s Arctic Front cryoballoon catheters

Treating AFib early with cryoablation reduces risk of disease progression, repeat hospitalization

“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.

November 10, 2022
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.

Bypass surgery the best way to limit amputations, death among CLTI patients

Researchers examined data from more than 1,800 CLTI patients, comparing bypass surgery with minimally invasive treatment options such as angioplasty and stenting.

November 7, 2022
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.

Fish oil, garlic and other ‘heart-healthy’ dietary supplements do not improve cholesterol levels

The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.

November 7, 2022
Extracorporeal membrane oxygenation (ECMO) can help patients with severe COVID-19 make a successful recovery. Venovenous ECMO (VV-ECMO) has the potential to minimize lung damage compared to conventional mechanical ventilation. ECMO unit in service with the COVID care unit at Banner Medical Center in Phoenix.

Early use of ECMO fails to improve cardiogenic shock outcomes, surprising cardiologists

"We expected to see a significant improvement in outcomes for patients with severe or rapidly progressing cardiogenic shock who underwent early ECMO treatment," one specialist said. 

November 7, 2022
HeartFlow FFR-CT

AI-powered CCTA outperforms usual care when evaluating stable chest pain

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

November 7, 2022
Displaying 89 - 96 of 158
Design by Adaptive Theme